| 1 |
33897064 | Impact of the Omics-Based Biomarkers on the Fluvoxamine's Steady-State Concentration, Efficacy and Safety in Patients with Affective Disorders Comorbid with Alcohol Use Disorder. | 2021 Jan 12 |
1 |
| 2 |
31795773 | Clinically relevant drug interactions between newer antidepressants and oral anticoagulants. | 2020 Jan |
1 |
| 3 |
30762305 | Physiologically-Based Pharmacokinetic Models for CYP1A2 Drug-Drug Interaction Prediction: A Modeling Network of Fluvoxamine, Theophylline, Caffeine, Rifampicin, and Midazolam. | 2019 May |
1 |
| 4 |
29155491 | Variation in the Response of Clozapine Biotransformation Pathways in Human Hepatic Microsomes to CYP1A2- and CYP3A4-selective Inhibitors. | 2018 Apr |
1 |
| 5 |
27402157 | Physiologically Based Pharmacokinetic Modeling of Palbociclib. | 2017 Feb |
1 |
| 6 |
26886336 | Dynamic and Static Simulations of Fluvoxamine-Perpetrated Drug-Drug Interactions Using Multiple Cytochrome P450 Inhibition Modeling, and Determination of Perpetrator-Specific CYP Isoform Inhibition Constants and Fractional CYP Isoform Contributions to Victim Clearance. | 2016 Mar |
1 |
| 7 |
23716885 | Effect of combination of aripiprazole with carbamazepine and fluvoxamine on liver functions in experimental animals. | 2013 Mar-Apr |
1 |
| 8 |
21739267 | The relationship between clinical pharmacokinetics of aripiprazole and CYP2D6 genetic polymorphism: effects of CYP enzyme inhibition by coadministration of paroxetine or fluvoxamine. | 2012 Jan |
1 |
| 9 |
21277363 | Involvement of CYP3A4/5 and CYP2D6 in the metabolism of aconitine using human liver microsomes and recombinant CYP450 enzymes. | 2011 Apr 10 |
1 |
| 10 |
19225771 | Effect of smoking and CYP2D6 polymorphisms on the extent of fluvoxamine-alprazolam interaction in patients with psychosomatic disease. | 2009 Jul |
2 |
| 11 |
19593168 | ABCB1 and cytochrome P450 polymorphisms: clinical pharmacogenetics of clozapine. | 2009 Aug |
1 |
| 12 |
19843060 | In vitro and in vivo evaluation of the inhibition potential of risperidone toward clozapine biotransformation. | 2009 Oct |
1 |
| 13 |
16226034 | Effect of fluvoxamine on plasma risperidone concentrations in patients with schizophrenia. | 2005 Dec |
2 |
| 14 |
16282844 | Fluvoxamine affects sildenafil kinetics and dynamics. | 2005 Dec |
1 |
| 15 |
11876575 | Selective serotonin reuptake inhibitors and cytochrome P-450 mediated drug-drug interactions: an update. | 2002 Feb |
1 |
| 16 |
12452751 | Fluvoxamine interaction with warfarin. | 2002 Dec |
1 |
| 17 |
11434513 | Use of midazolam urinary metabolic ratios for cytochrome P450 3A (CYP3A) phenotyping. | 2001 Jun |
1 |
| 18 |
11519155 | [Pharmacokinetics and drug interactions of antidepressive agents]. | 2001 Aug |
1 |
| 19 |
11038165 | Formation of a dihydroxy metabolite of phenytoin in human liver microsomes/cytosol: roles of cytochromes P450 2C9, 2C19, and 3A4. | 2000 Nov |
2 |
| 20 |
11085201 | Fluvoxamine. An updated review of its use in the management of adults with anxiety disorders. | 2000 Oct |
1 |
| 21 |
10192828 | O- and N-demethylation of venlafaxine in vitro by human liver microsomes and by microsomes from cDNA-transfected cells: effect of metabolic inhibitors and SSRI antidepressants. | 1999 May |
2 |
| 22 |
10471171 | Metabolic interactions of central nervous system medications and selective serotonin reuptake inhibitors. | 1999 May |
1 |
| 23 |
9469504 | Interactions between cyclosporine and newer antidepressant medications. | 1998 Feb |
1 |
| 24 |
9757149 | Effect of fluvoxamine therapy on the activities of CYP1A2, CYP2D6, and CYP3A as determined by phenotyping. | 1998 Sep |
5 |
| 25 |
9923581 | The effect of fluvoxamine on the pharmacokinetics and pharmacodynamics of buspirone. | 1998 Nov-Dec |
1 |
| 26 |
9184622 | Clinical pharmacokinetics of fluvoxamine: applications to dosage regimen design. | 1997 |
1 |
| 27 |
9353355 | Different contributions of cytochrome P450 2C19 and 3A4 in the oxidation of omeprazole by human liver microsomes: effects of contents of these two forms in individual human samples. | 1997 Nov |
3 |
| 28 |
8968657 | Pharmacokinetic-pharmacodynamic relationship of the selective serotonin reuptake inhibitors. | 1996 Dec |
1 |
| 29 |
8986013 | Non-response to citalopram in depressive patients: pharmacokinetic and clinical consequences of a fluvoxamine augmentation. | 1996 Dec |
1 |
| 30 |
9032002 | Pharmacokinetic drug interaction potential of selective serotonin reuptake inhibitors. | 1996 Dec |
1 |
| 31 |
7622807 | Comparative pharmacokinetics of selective serotonin reuptake inhibitors: a look behind the mirror. | 1995 Mar |
1 |
| 32 |
8567194 | Cytochrome P450 monooxygenases and interactions of psychotropic drugs: a five-year update. | 1995 |
1 |
| 33 |
8846617 | Overview of the pharmacokinetics of fluvoxamine. | 1995 |
1 |